top of page
Tom’s Journey with Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Tom shares his journey living with recurrent LG-IR-NMIBC and talks about his participation in the ENVISION clinical trial. Visit ZUSDURI.com for Full Prescribing and Patient Information. Sponsored by UroGen Pharma Ltd.
bottom of page